Recently Registered Midazolam Doses for Preterm Neonates Do Not Lead to Equal Exposure: A Population Pharmacokinetic Model

Although midazolam is a frequently used sedative in neonatal intensive care units, its use in preterm neonates has been off‐label. Recently, a new dosing advice for midazolam for sedation on intensive care units has been included in the label (0.03 mg/[kg·h] for preterm neonates <32 weeks and 0.0...

Descripción completa

Detalles Bibliográficos
Autores principales: Völler, Swantje, Flint, Robert B., Beggah, Fouzi, Reiss, Irwin, Andriessen, Peter, Zimmermann, Luc J.I., van den Anker, John N., Liem, Kian D., Koch, Birgit C.P., de Wildt, Saskia, Knibbe, Catherijne A.J., Simons, Sinno H.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Pediatric Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767398/
https://www.ncbi.nlm.nih.gov/pubmed/31093992
http://dx.doi.org/10.1002/jcph.1429

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767398/
https://www.ncbi.nlm.nih.gov/pubmed/31093992
http://dx.doi.org/10.1002/jcph.1429

Ejemplares similares